Search results
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 4 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Why Do I Have a Rash Between My Breasts?
Verywell Health via Yahoo News· 2 days agoA rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 6 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Ultravate side effects: What they are and how to manage them
Healthline· 7 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to serious. Specifically ...
Research shows linked biological pathways driving skin inflammation
Medical Xpress· 6 days agoLed by researchers at NYU Langone Health, the new study found that the interleukin-17 (IL-17)...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 7 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 4 days agoTwice-daily doses of Palisade's oral prodrug PALI-2108 for eight days protected mouse models of...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 6 days agoLuckily, sales of Rinvoq, an arthritis tablet, and Skyrizi, a psoriasis injection, offset the loss....
Do LED Skin-Care Devices Even Work?
New York Magazine· 5 days agoLight therapy via at-home LED (light-emitting diodes) devices is trending in skin care right now, but it’s not just a fad. According to Dr. Jared Jagdeo,...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? | The Motley...
The Motley Fool· 6 days agoWall Street is feeling pretty good about AbbVie's (ABBV -1.19%) performance in 2024 so far. Chen...